Dr. Abdullah Kahraman's research focuses on omics-based biomarker and drug-target detection across cancer types. He and his lab at FHNW focus in particular on the detection of cancer-specific alternative splicing events driving oncogenesis, progression, and metastatic processes. For their investigations, they use data science and machine learning methods and integrate data from whole-genome, whole-exome, and targeted DNA sequencing; RNA sequencing; mass spectrometry-based proteomics and peptidomics; protein structures; and protein interaction networks. 

Abdullah works together with the CTP Lab as a permanent scientific guest.